Effects of chronic β-adrenergic blockade on the left ventricular and cardiocyte abnormalities of chronic canine mitral regurgitation

Journal of Clinical Investigation

Volumn 93, Issue 6, 1994, Pages 2639-2648

  Tsutsui, Hiroyuki ^a   Spinale, Francis G ^a   Nagatsu, Masayoshi ^a   Schmid, Phillip G ^c   Ishihara, Kazuaki ^a   DeFreyte, Gilberto ^a   Cooper IV, George ^a,b   Carabello, Blase A ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

adrenergic receptor blockaders; congestive hypertrophy; left heart failure; mitral valve insufficiency; ventricular function

Indexed keywords

ATENOLOL; ESMOLOL; ISOPRENALINE; NORADRENALIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CONTROLLED STUDY; DOG; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; INTRAVENOUS DRUG ADMINISTRATION; LUNG WEDGE PRESSURE; MITRAL VALVE REGURGITATION; MORPHOMETRICS; MUSCLE FIBRIL; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0028283241     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI117277     Document Type: Article

References (64)

1. Schuler, G., K. L. Peterson, A. Johnson, G. Francis, G. Dennish, J. Utley, P. O. Daily, W. Ashburn, and J. Ross Jr. 1979. Temporal response of left ventricular performance to mitral valve surgery. Circulation. 59:1218-1231.
2. Eckberg, D. L., J. H. Gault, R. L. Bouchard, J. S. Karliner, and J. Ross, Jr. 1973. Mechanics of left ventricular contraction in chronic severe mitral regurgitation. Circulation. 47:1252-1259.
3. Urabe, Y., D. L. Mann, R. L. Kent, K. Nakano, R. J. Tomanek, B. A. Carabello, and G. Cooper IV. 1992. Cellular and ventricular contractile dysfunction in experimental canine mitral regurgitation. Circ. Res. 70:131-147.
4. Mulieri, L. A., B. J. Leavitt, F. P. Ittleman, B. J. Martin, J. R. Haeberle. and N. R. Alpert. 1993. Forskolin reverses the force-frequency defect in left ventricular subepicardium (EPI) but not in papillary myocardium (PAP) in human mitral regurgitation heart failure. Circulation. 88:1-406. (Abstr.)
5. Grossman, W., D. Jones, and L. P. McLaurin. 1975. Wall stress and patterns of hypertrophy in the human left ventricle. J. Clin. Invest. 56:56-64.
6. Corin, W. J., T. Murakami, E. S. Monrad, O. M. Hess, and H. P. Krayenbuehl. 1991. Left ventricular passive diastolic properties in chronic mitral regurgitation. Circulation. 83:797-807.
7. Wisenbaugh, T. 1988. Does normal pump function belie muscle dysfunction in patients with chronic severe mitral regurgitation? Circulation. 77:515-525.
8. Hochreiter, C., N. Niles, R. B. Devereux, P. Kligfield, and J. S. Borer. 1986. Mitral regurgitation: relationship of noninvasive descriptors of right and left ventricular performance to clinical and hemodynamic findings and to prognosis in medically and surgically treated patients. Circulation. 73:900-912.
9. Monrad, E. S., O. M. Hess, T. Murakami, H. Nonogi, W. J. Corin, and H. P Krayenbuehl. 1988. Time course of regression of left ventricular hypertrophy after aortic valve replacement. Circulation. 77:1345-1355.
10. Wisenbaugh, T., J. F. Spann, and B. A. Carabello. 1984. Differences in myocardial performance and load between patients with similar amounts of chronic aortic versus chronic mitral regurgitation. J. Am Coll. Cardiol. 3:916-923.
11. Huber, D., J. Grimm, R. Koch, and H. P. Krayenbuehl. 1981. Determinants of ejection performance in aortic stenosis. Circulation. 64:126-134.
12. Dodge, H. T., J. W. Kennedy, and J. L. Petersen. 1973. Quantitative angiographic methods in the evaluation of valvular heart disease. Prog. Cardiovasc. Dis. 16:1-23.
13. Carabello, B. A., M. R. Zile, R. Tanaka, and G. Cooper IV. 1992. Left ventricular hypertrophy due to volume overload versus pressure overload. Am. J. Physiol. 263:H1137-H1144.
14. Ross, J. Jr., E. H. Sonnenblick, R. R. Taylor, H. M. Spotnitz, and J. W. Covell. 1971. Diastolic geometry and sarcomere lengths in the chronically dilated canine left ventricle. Circ. Res. 28:49-61.
15. Nagatsu, M., M. R. Zile, H. Tsutsui, P. G. Schmid, G. DeFreyte, G. Cooper IV, and B. A. Carabello. 1994. Native beta-adrenergic support for left ventricular dysfunction in experimental mitral regurgitation normalizes indexes of pump and contractile function. Circulation. 89:818-826.
16. Gaffney, T. E., and E. Braunwald. 1963. Importance of the adrenergic nervous system in the support of circulatory function in patients with congestive heart failure. Am. J. Med. 34:320-324.
17. Mann, D. L., R. L. Kent, B. Parsons, and G. Cooper IV. 1992. Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation. 85:790-804.
18. Swedberg, K., F. Waagstein, A. Hjalmarson, and I. Wallentin. 1979. Prolongation of survival in congestive cardiomyopathy by beta-receptor blockade. Lancet. 1:1374-1376.
19. Eichhorn, E. J., J. B. Bedotto, C. R. Malloy, B. A. Hatfield, D. Deitchman, M. Brown, J. E. Willard, and P. A. Grayburn. 1990. Effect of β-adrenergic blockade on myocardial function and energetics in congestive heart failure. Improvements in hemodynamic, contractile, and diastolic performance with bucindolol. Circulation. 82:473-483.
20. Anderson, J. L., E. M. Gilbert, J. B. O'Connell, D. Renlund, F. Yanowitz, M. Murray, M. Roskelley, P. Mealey, K. Volkman, D. Deitchman, et al. 1991. Long-term (2 year) beneficial effects of beta-adrenergic blockade with bucindolol in patients with idiopathic dilated cardiomyopathy. J. Am. Coll. Cardiol. 17:1373-1381.
21. Woodley, S. L., E. M. Gilbert, J. L. Anderson, J. B. O'Connell, D. Deitchman. F. G. Yanowitz, P. C. Mealey, K. Volkman, D. G. Renlund, R. Menlove, et al. 1991. β-blockade with bucindolol in heart failure caused by ischemic versus idiopathic dilated cardiomyopathy. Circulation. 84:2426-2441.
22. Bristow, M. R., R. Ginsburg, W. Minobe, R. S. Cubicciotti, W. S. Sageman, K. Lurie, M. E. Billingham, D. C. Harrison, and E. B. Stinson. 1982. Decreased catecholamine sensitivity and β-adrenergic-receptor density in failing human hearts. N. Engl J. Med. 307:205-211.
23. Vatner, D. E., S. F. Vatner, J. Nejima, N. Uemura, E. E. Susanni, T. H. Hintze, and C. J. Homcy. 1989. Chronic norepinephrine elicits desensitization by uncoupling the beta-receptor. J. Clin. Invest. 84:1741-1748.
24. Heilbrunn, S. M., P. Shah, M. R. Bristow, H. A. Valantine, R. Ginsburg, and M. B. Fowler. 1989. Increased β-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy. Circulation. 79:483-490.
25. Rona, G., C. I. Chappel, T. Balazs, and R. Gaudry. 1959. An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat. AMA Arch. Pathol. 67:443-455.
26. Fleckenstein, A., J. Janke, H. J. Doring, and O. Pachinger. 1973. Ca overload as the determinant factor in the production of catecholamine-induced myocardial lesions. Recent Adv. Study Card. Struct Metab. 2:455-466.
27. Carabello, B. A., K. Nakano, W. Corin, R. Biederman, J. F. Spann, Jr. 1989. Left ventricular function in experimental volume overload hypertrophy. Am. J Physiol. 256:H974-H981.
28. Nakano, K., M. M. Swindle, F.Spinale, K. Ishihara, S. Kanazawa, A. Smith, R. W. W. Biederman, L. Clamp, Y. Hamada, M. R. Zile, et al. 1991. Depressed contractile function due to canine mitral regurgitation improves after correction of the volume overload. J. Clin. Invest. 87:2077-2086.
29. Carabello, B. A., K. Nakano, K. Ishihara, S. Kanazawa, R. W. W. Biederman, and J. F. Spann, Jr. 1991. Coronary blood flow in dogs with contractile dysfunction due to experimental volume overload. Circulation. 83:1063-1075.
30. 2+ tolerance, electrophysiology, and ultrastructure. Am. J. Physiol. 245:H830-H839.
31. Kent, R. L., D. L. Mann, Y. Urabe, R. Hisano, K. W. Hewett, M. Lough-nane, and G. Cooper. 1989. The contractile function of isolated feline cardiocytes in response to viscous loading. Am. J Physiol. 257:H1717-H1727.
32. Nakano, K., M. Sugawara, K. Ishihara, S. Kanazawa, W. J. Corin, S. Denslow, R. W. W. Biederman, and B. A. Carabello. 1990. Myocardial stiffness derived from end-systolic wall stress and the logarithm of the reciprocal of wall thickness: A contractility index independent of ventricular size. Circulation. 82:1352-1361.
33. Corin, W. J., M. M. Swindle, J. F. Spann, Jr., K. Nakano, M. Frankis, R. W. W. Biederman, A. Smith, A. Taylor, and B. A. Carabello. 1988. The mechanism of decreased forward stroke volume in children and swine with ventricular septal defect and failure to thrive. J. Clin. Invest. 82:544-551.
34. Suga, H., R. Hisano, Y. Goto, and O. Yamada. 1984. Normalization of end-systolic pressure-volume relation and Emax of different sized hearts. Jpn. Circ. J. 48:136-143.
35. Belcher, P., L. E. Boerboom, and G. N. Olinger. 1985. Standardization of end-systolic pressure-volume relation in the dog. Am. J. Physiol. 249:H547-H553.
36. Krahwinkel, D. J. Jr., D. C. Sawyer, G. E. Eyster, and G. Bender G. 1975. Cardiopulmonary effects of fentanyl-droperidol, nitrous oxide, and atropine sulfate in dogs. Am. J. Vet. Res. 36:1211-1219.
37. Kleaveland, J. P., W. G. Kussmaul, T. Vinciguerra, R. Diters, and B. A. Carabello. 1988. Volume overload hypertrophy in a closed-chest model of mitral regurgitation. Am. J. Physiol. 254:H1034-H1041.
38. Bristow, M. R., R. E. Hershberger, J. D. Port, W. Minobe, and R. Rasmussen. 1989. Beta 1- and beta 2-adrenergic receptor-mediated adenylate cyclase stimulation in nonfailing and failing human ventricular myocardium. Mol. Pharmacol. 35:295-303.
39. Peuler, J. D., and G. A. Johnson. 1977. Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine. Life Sci. 21:625-636.
40. Krueger, J. W., D. Forletti, and B. A. Wittenberg. 1980. Uniform sarcomere shortening behavior in isolated cardiac muscle cells. J. Gen. Physiol. 76:587-607.
41. Wussling, M., W. Schenk, and B. Nilius. 1987. A study of dynamic properties in isolated myocardial cells by the laser diffraction method. J. Mol. Cell. Cardiol. 19:897-907.
42. Pollard, T. D. 1982. A falling ball apparatus to measure filament cross-linking. Methods Cell. Biol. 24:301-311.
43. Edman, K. A., and J. C. Hwang. 1977. The force-velocity relationship in vertebrate muscle fibres at varied tonicity of the extracellular medium. J. Physiol. (Lond.). 269:255-272.
44. Wildenthal, K., C. L. Skelton, and H. N. Coleman. 1969. Cardiac muscle mechanics in hyperosmotic solutions. Am. J. Physiol. 217:302-306.
45. Roos, K. P. 1986. Length, width, and volume changes in osmotically stressed myocytes. Am. J. Physiol. 251:H1373-H1378.
46. Spinale, F. G., J. L. Zellner, M. Tomita, F. A. Crawford, and M. R. Zile. 1991. Relation between ventricular and myocyte remodeling with the development and regression of supraventricular tachycardia-induced cardiomyopathy. Circ. Res. 69:1058-1067.
47. Spinale, F. G., F. A. Crawford, Jr., K. W. Hewett, and B. A. Carabello. 1991. Ventricular failure and cellular remodeling with chronic supraventricular tachycardia. J. Thorac. Cardiovasc. Surg. 102:874-882.
48. Hansen-Smith, F. M., L. Watson, and G. R. Joswiak 1989. Postnatal changes in capillary density of rat sternomastoid muscle. Am. J. Physiol. 257:H344-H347.
49. Spinale, F. G., R. C. Grine, G. E. Tempel, F. A. Crawford, and M. R. Zile. 1992. Alterations in the myocardial capillary vasculature accompany tachycardia induced cardiomyopathy. Bas. Res. Cardiol. 87:65-79.
50. Spinale, F. G., R. Tanaka, F. A. Crawford, and M. R. Zile. 1992. Changes l in myocardial blood flow during development of and recovery from tachycardiainduced cardiomyopathy. Circulation. 85:717-729.
51. Mendez, J., and A. Keys. 1960. Density and composition of mammalian muscle. Metab. Clin. Exp. 9:184-188.
52. Bishop, S. P., S. Oparil, R. H. Reynolds, and J. L. Drummond. 1979. Regional myocyte size in normotensive and spontaneously hypertensive rats. Hypertension. 1:378-383.
53. Rackley, C. E., H. T. Dodge, Y. D. Coble, Jr., and R. E. Hay. 1964. A method for determining left ventricular mass in man. Circulation 29:666-671.
54. Mirsky, I. 1969. Left ventricular stresses in the intact human heart. Biophys. J. 9:189-208.
55. Francis, G. S., C. Benedict, D. E. Johnstone, P. C. Kirlin, J. Nicklas, C. S. Liang, S. H. Kubo, E. Rudin-Toretsky, and S. Yusuf. 1990. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure: a substudy of the Studies of Left Venticular Dysfunction (SOLVD). Circulation. 82:1724-1729.
56. Waagstein, F., K. Caidahl, I. Wallentin, C. H. Bergh, and A. Hjalmarson. 1989. Long-term β-blockade in dilated cardiomyopathy. Effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol. Circulation 80:551-563.
57. Engelmeier, R. S., J. B. O'Connell, R. Walsh, N. Rad, P. J Scanlon, and R. M. Gunnar. 1985. Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial. Circulation. 72:536-546.
58. Schaffer, M. S., P. Zuberbuhler, G. Wilson, V. Rose, W. J. Duncan, and R. D. Rowe. 1981. Catecholamine cardiomyopathy: an unusual presentation of pheochromocytoma in children. J. Pediatr. 99:276-279.
59. Lam, J. B., C. Shub, and S. G. Sheps. 1985. Reversible dilatation of hypertrophied left ventricle in pheochromocytoma: serial two-dimensional echocardiographic observations. Am. Heart J. 109:613-615.
60. Imperato-McGinley, J., T. Gautier, K. Ehlers, M. A. Zullo, D. S. Goldstein, and E. D. Vaughan. 1987. Reversibility of catecholamine-induced dilated cardiomyopathy in a child with a pheochromocytoma. N. Engl J Med. 316:793-797.
61. Wier, W. G., and D. T. Yue. 1986. Intracellular calcium transients underlying the short-term force-interval relationship in ferret ventricular myocardium. J. Physiol (Lond.). 376:507-530.
62. Mulieri, L. A., G. Hasenfuss, B. Leavitt, P. D. Allen, and N. R. Alpert. 1992. Altered myocardial force-frequency relation in human heart failure. Circulation. 85:1743-1750.
63. Simpson, P. 1983. Norepinephrine-stimulated hypertrophy of cultured rat myocardial cells is an alpha, adrenergic response. J. Clin. Invest. 72:732-738.
64. Gerdes, A. M., J. A. Moore, J. M. Hines, P. A. Kirkland, and S. P. Bishop. 1986. Regional differences in myocyte size in normal rate heart. Anat. Res. 215:420-426.